Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M98,721Revenue (TTM) $M36,227Net Margin (%)12.9Altman Z-Score1.9
Enterprise Value $M112,301EPS (TTM) $1.8Operating Margin %14.7Piotroski F-Score7
P/E(ttm)21.3Beneish M-Score-2.8Pre-tax Margin (%)13.6Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %0.4Quick Ratio1.0Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %-2.8Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow14.7y-y EBITDA Growth Rate %-16.8ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %4.3PEG--ROE % (ttm)7.5Less Shares Outstanding y-yY
Payout Ratio %92.0Shares Outstanding M2,574ROIC % (ttm)6.6Gross Margin Increase y-yY

Gurus Latest Trades with SNY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYNWQ Managers 2016-06-30 Sold Out -1.22%$38.13 - $44.32
($40.99)
$ 38.35-6%Sold Out0
SNYDavid Dreman 2016-06-30 Add0.47%$38.13 - $44.32
($40.99)
$ 38.35-6%Add 980.43%20,204
SNYHOTCHKIS & WILEY 2016-06-30 Add0.23%$38.13 - $44.32
($40.99)
$ 38.35-6%Add 12.47%11,432,112
SNYJohn Paulson 2016-06-30 Buy 0.17%$38.13 - $44.32
($40.99)
$ 38.35-6%New holding395,500
SNYDodge & Cox 2016-06-30 Add0.07%$38.13 - $44.32
($40.99)
$ 38.35-6%Add 3.04%55,155,913
SNYBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.06%$38.13 - $44.32
($40.99)
$ 38.35-6%Reduce -3.32%28,122,279
SNYCharles Brandes 2016-06-30 Add0.03%$38.13 - $44.32
($40.99)
$ 38.35-6%Add 1.24%3,600,731
SNYKen Fisher 2016-06-30 Add0.01%$38.13 - $44.32
($40.99)
$ 38.35-6%Add 0.67%13,638,183
SNYJoel Greenblatt 2016-06-30 Add$38.13 - $44.32
($40.99)
$ 38.35-6%Add 2.45%35,571
SNYCharles Brandes 2016-03-31 Add0.78%$38.37 - $42.65
($40.17)
$ 38.35-5%Add 61.76%3,556,721
SNYDodge & Cox 2016-03-31 Add0.14%$38.37 - $42.65
($40.17)
$ 38.35-5%Add 7.24%53,530,129
SNYNWQ Managers 2016-03-31 Reduce-0.09%$38.37 - $42.65
($40.17)
$ 38.35-5%Reduce -6.34%1,946,427
SNYBill Nygren 2016-03-31 Reduce-0.05%$38.37 - $42.65
($40.17)
$ 38.35-5%Reduce -3.53%5,470,000
SNYBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.03%$38.37 - $42.65
($40.17)
$ 38.35-5%Reduce -1.36%29,087,790
SNYJoel Greenblatt 2016-03-31 Buy 0.02%$38.37 - $42.65
($40.17)
$ 38.35-5%New holding34,720
SNYDavid Dreman 2016-03-31 Buy 0.01%$38.37 - $42.65
($40.17)
$ 38.35-5%New holding1,870
SNYKen Fisher 2016-03-31 Add0.01%$38.37 - $42.65
($40.17)
$ 38.35-5%Add 0.97%13,546,950
SNYMario Gabelli 2016-03-31 Sold Out $38.37 - $42.65
($40.17)
$ 38.35-5%Sold Out0
SNYHOTCHKIS & WILEY 2016-03-31 Add$38.37 - $42.65
($40.17)
$ 38.35-5%Add 0.23%10,164,994
SNYNWQ Managers 2015-12-31 Reduce-0.31%$41.51 - $51.49
($45.91)
$ 38.35-16%Reduce -16.94%2,078,119
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-59.63view
Sanofi10% Owner 2015-01-26Buy647,448$95-59.63view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-58.84view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-42.66view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67400view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    John Paulson Trims Synergy Sep 23 2016 
    Buffett Stock Wells Fargo Falls to 52-Week Low After Scandal Sep 22 2016 
    Sanofi Sues Merck Over Patent Infringement Sep 20 2016 
    Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap Sep 19 2016 
    Guru Buys Barclays, Office Depot, Morgan Stanley Sep 13 2016 
    MS Global Gains International Flavors, Coca-Cola Sep 08 2016 
    Is Bristol-Myers Squibb Presenting an Opportunity? Sep 08 2016 
    Gilead Was Smart to Let Medivation Slip Through its Fingers Aug 29 2016 
    Sanofi's Risk Increases on Acquisition Miss Aug 28 2016 
    Why Berkshire Hathaway Dumped Johnson & Johnson Jul 19 2016 

    More From Other Websites
    Sanofi may win U.S. approval of $3 billion eczema drug by March Sep 26 2016
    Sanofi may win U.S. approval of $3 bln eczema drug by March Sep 26 2016
    Sanofi may win U.S. approval of $3 bln eczema drug by March Sep 26 2016
    Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review... Sep 26 2016
    Coverage initiated on Sanofi by Piper Jaffray Sep 23 2016
    Hard to swallow: emerging markets get tougher for drugmakers Sep 22 2016
    Hard to swallow: emerging markets get tougher for drugmakers Sep 22 2016
    Hard to swallow - emerging markets get tougher for drugmakers Sep 22 2016
    Hard to swallow: emerging markets get tougher for drugmakers Sep 22 2016
    Buffett Stock Wells Fargo Falls Close to 52-Week Low Post Scandal Sep 22 2016
    New Setback for Sanofi's Lantus Increases Need for M&A Sep 22 2016
    Cone Snail Venom Could Inspire Fast-Acting Insulin For Diabetes Sep 21 2016
    Sanofi Sues Merck Over Patent Infringement Sep 20 2016
    The 5 Top-Selling Drugs In The World Sep 20 2016
    Business Watch Sep 19 2016
    Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap Sep 19 2016
    [$$] Sanofi Files Suit Against Merck Sep 19 2016
    Sanofi Fighting a Losing Battle, Sues Merck for Alleged Patent Infrigement Sep 19 2016
    5 Things You Must Know Before the Market Opens Monday Sep 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)